[{"id":"842583e2-8e92-49fc-94d6-2f73865d1b14","acronym":"","url":"https://clinicaltrials.gov/study/NCT07203352","created_at":"2025-10-04T08:00:11.817Z","updated_at":"2025-10-04T08:00:11.817Z","phase":"Phase 3","brief_title":"Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL","source_id_and_acronym":"NCT07203352","lead_sponsor":"Nanfang Hospital, Southern Medical University","biomarkers":" ABL2","pipe":"","alterations":" ","tags":["ABL2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e sorafenib"],"overall_status":"Recruiting","enrollment":" Enrollment 154","initiation":"Initiation: 10/01/2025","start_date":" 10/01/2025","primary_txt":" Primary completion: 12/01/2026","primary_completion_date":" 12/01/2026","study_txt":" Completion: 12/30/2026","study_completion_date":" 12/30/2026","last_update_posted":"2025-10-02"},{"id":"1c2892ea-1261-4dae-afe1-c46131b3f056","acronym":"","url":"https://clinicaltrials.gov/study/NCT07039760","created_at":"2025-06-28T13:40:51.525Z","updated_at":"2025-06-28T13:40:51.525Z","phase":"Phase 1","brief_title":"Asciminib With or Without Sildenafil for Brain Tumors","source_id_and_acronym":"NCT07039760","lead_sponsor":"Washington University School of Medicine","biomarkers":" CRKL • ABL2","pipe":"","alterations":" ","tags":["CRKL • ABL2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Scemblix (asciminib) • sildenafil"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 12","initiation":"Initiation: 12/01/2025","start_date":" 12/01/2025","primary_txt":" Primary completion: 06/01/2027","primary_completion_date":" 06/01/2027","study_txt":" Completion: 06/01/2027","study_completion_date":" 06/01/2027","last_update_posted":"2025-06-26"},{"id":"e02e570e-b7ca-4ba0-9f90-781b4b6e5d51","acronym":"PDT-Ph-Like","url":"https://clinicaltrials.gov/study/NCT03564470","created_at":"2021-01-18T17:32:32.370Z","updated_at":"2024-07-02T16:36:07.913Z","phase":"Phase 2/3","brief_title":"Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL","source_id_and_acronym":"NCT03564470 - PDT-Ph-Like","lead_sponsor":"Nanfang Hospital of Southern Medical University","biomarkers":" ABL2","pipe":"","alterations":" ","tags":["ABL2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e dasatinib • cytarabine • cyclophosphamide • Epidaza (chidamide)"],"overall_status":"Recruiting","enrollment":" Enrollment 120","initiation":"Initiation: 02/14/2016","start_date":" 02/14/2016","primary_txt":" Primary completion: 08/30/2023","primary_completion_date":" 08/30/2023","study_txt":" Completion: 08/30/2023","study_completion_date":" 08/30/2023","last_update_posted":"2022-07-01"}]